These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
[x]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
[_]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
94-3177549
|
(State or Other Jurisdiction of
|
(I.R.S. Employer
|
Incorporation or Organization)
|
Identification No.)
|
Large accelerated filer
x
|
Accelerated filer
o
|
Non-accelerated filer
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
o
|
|
|
Page
|
|
|
|
|
|
|
Financial Statements (Unaudited)
|
|
|
|
|
|
|
a) Condensed Consolidated Statements of Income for the three and nine months ended October 25, 2015 and October 26, 2014
|
|
|
|
|
|
b) Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended October 25, 2015 and October 26, 2014
|
|
|
|
|
|
c) Condensed Consolidated Balance Sheets as of October 25, 2015 and January 25, 2015
|
|
|
|
|
|
d) Condensed Consolidated Statements of Cash Flows for the nine months ended October 25, 2015 and October 26, 2014
|
|
|
|
|
|
e) Notes to Condensed Consolidated Financial Statements
|
|
|
|
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
||
|
|
|
Quantitative and Qualitative Disclosures About Market Risk
|
||
|
|
|
Controls and Procedures
|
||
|
|
|
|
|
|
|
|
|
Legal Proceedings
|
||
|
|
|
Risk Factors
|
||
|
|
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
||
|
|
|
Exhibits
|
||
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 25,
|
|
October 26,
|
|
October 25,
|
|
October 26,
|
||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
|
|
|
|
|
|
|
|
||||||||
Revenue
|
$
|
1,305
|
|
|
$
|
1,225
|
|
|
$
|
3,609
|
|
|
$
|
3,431
|
|
Cost of revenue
|
571
|
|
|
549
|
|
|
1,589
|
|
|
1,531
|
|
||||
Gross profit
|
734
|
|
|
676
|
|
|
2,020
|
|
|
1,900
|
|
||||
Operating expenses
|
|
|
|
|
|
|
|
||||||||
Research and development
|
329
|
|
|
340
|
|
|
987
|
|
|
1,011
|
|
||||
Sales, general and administrative
|
152
|
|
|
123
|
|
|
441
|
|
|
361
|
|
||||
Restructuring and other charges
|
8
|
|
|
—
|
|
|
97
|
|
|
—
|
|
||||
Total operating expenses
|
489
|
|
|
463
|
|
|
1,525
|
|
|
1,372
|
|
||||
Income from operations
|
245
|
|
|
213
|
|
|
495
|
|
|
528
|
|
||||
Interest income
|
9
|
|
|
7
|
|
|
28
|
|
|
20
|
|
||||
Interest expense
|
(12
|
)
|
|
(11
|
)
|
|
(35
|
)
|
|
(35
|
)
|
||||
Other income, net
|
3
|
|
|
—
|
|
|
1
|
|
|
14
|
|
||||
Income before income tax
|
245
|
|
|
209
|
|
|
489
|
|
|
527
|
|
||||
Income tax expense (benefit)
|
(1
|
)
|
|
36
|
|
|
83
|
|
|
90
|
|
||||
Net income
|
$
|
246
|
|
|
$
|
173
|
|
|
$
|
406
|
|
|
$
|
437
|
|
|
|
|
|
|
|
|
|
||||||||
Net income per share:
|
|
|
|
|
|
|
|
|
|
||||||
Basic
|
$
|
0.45
|
|
|
$
|
0.32
|
|
|
$
|
0.75
|
|
|
$
|
0.79
|
|
Diluted
|
$
|
0.44
|
|
|
$
|
0.31
|
|
|
$
|
0.72
|
|
|
$
|
0.77
|
|
|
|
|
|
|
|
|
|
||||||||
Weighted average shares used in per share computation:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic
|
542
|
|
|
548
|
|
|
544
|
|
|
555
|
|
||||
Diluted
|
565
|
|
|
558
|
|
|
563
|
|
|
566
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Cash dividends declared and paid per common share
|
$
|
0.0975
|
|
|
$
|
0.0850
|
|
|
$
|
0.2800
|
|
|
$
|
0.2550
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 25,
|
|
October 26,
|
|
October 25,
|
|
October 26,
|
||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
|
|
||||||||||||||
Net income
|
$
|
246
|
|
|
$
|
173
|
|
|
$
|
406
|
|
|
$
|
437
|
|
Other comprehensive income (loss), net of tax:
|
|
|
|
|
|
|
|
||||||||
Net change in unrealized gains (losses) on available-for-sale securities
|
3
|
|
|
5
|
|
|
(1
|
)
|
|
5
|
|
||||
Change in fair value of interest rate swap
|
(3
|
)
|
|
—
|
|
|
(3
|
)
|
|
—
|
|
||||
Reclassification adjustments for net realized losses on available-for-sale securities included in net income
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
—
|
|
||||
Other comprehensive income (loss)
|
—
|
|
|
5
|
|
|
(6
|
)
|
|
5
|
|
||||
Total comprehensive income
|
$
|
246
|
|
|
$
|
178
|
|
|
$
|
400
|
|
|
$
|
442
|
|
|
October 25,
|
|
January 25,
|
||||
|
2015
|
|
2015
|
||||
ASSETS
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
471
|
|
|
$
|
497
|
|
Marketable securities
|
4,257
|
|
|
4,126
|
|
||
Accounts receivable, net
|
536
|
|
|
474
|
|
||
Inventories
|
425
|
|
|
483
|
|
||
Prepaid expenses and other current assets
|
93
|
|
|
70
|
|
||
Deferred income taxes
|
52
|
|
|
63
|
|
||
Total current assets
|
5,834
|
|
|
5,713
|
|
||
Property and equipment, net
|
477
|
|
|
557
|
|
||
Goodwill
|
618
|
|
|
618
|
|
||
Intangible assets, net
|
172
|
|
|
222
|
|
||
Other assets
|
73
|
|
|
91
|
|
||
Total assets
|
$
|
7,174
|
|
|
$
|
7,201
|
|
|
|
|
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
295
|
|
|
$
|
293
|
|
Accrued and other current liabilities
|
560
|
|
|
603
|
|
||
Total current liabilities
|
855
|
|
|
896
|
|
||
|
|
|
|
||||
Long-term debt
|
1,406
|
|
|
1,384
|
|
||
Other long-term liabilities
|
437
|
|
|
489
|
|
||
Capital lease obligations, long-term
|
11
|
|
|
14
|
|
||
Commitments and contingencies - see Note 12
|
—
|
|
|
—
|
|
||
Shareholders’ equity:
|
|
|
|
||||
Preferred stock
|
—
|
|
|
—
|
|
||
Common stock
|
1
|
|
|
1
|
|
||
Additional paid-in capital
|
4,170
|
|
|
3,855
|
|
||
Treasury stock, at cost
|
(3,912
|
)
|
|
(3,395
|
)
|
||
Accumulated other comprehensive income
|
2
|
|
|
8
|
|
||
Retained earnings
|
4,204
|
|
|
3,949
|
|
||
Total shareholders' equity
|
4,465
|
|
|
4,418
|
|
||
Total liabilities and shareholders' equity
|
$
|
7,174
|
|
|
$
|
7,201
|
|
|
Nine Months Ended
|
||||||
|
October 25,
|
|
October 26,
|
||||
|
2015
|
|
2014
|
||||
Cash flows from operating activities:
|
|
|
|
||||
Net income
|
$
|
406
|
|
|
$
|
437
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
151
|
|
|
166
|
|
||
Stock-based compensation expense
|
145
|
|
|
115
|
|
||
Restructuring and other charges
|
37
|
|
|
—
|
|
||
Amortization of debt discount
|
22
|
|
|
21
|
|
||
Net gain on sale and disposal of long-lived assets and investments
|
(7
|
)
|
|
(18
|
)
|
||
Deferred income taxes
|
107
|
|
|
62
|
|
||
Tax benefits from stock-based compensation
|
(5
|
)
|
|
(12
|
)
|
||
Other
|
16
|
|
|
19
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
||||
Accounts receivable
|
(63
|
)
|
|
(138
|
)
|
||
Inventories
|
59
|
|
|
(20
|
)
|
||
Prepaid expenses and other assets
|
(25
|
)
|
|
5
|
|
||
Accounts payable
|
7
|
|
|
10
|
|
||
Accrued and other current liabilities
|
(41
|
)
|
|
(23
|
)
|
||
Other long-term liabilities
|
(145
|
)
|
|
(161
|
)
|
||
Net cash provided by operating activities
|
664
|
|
|
463
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Purchases of marketable securities
|
(2,669
|
)
|
|
(2,126
|
)
|
||
Proceeds from sale of marketable securities
|
1,651
|
|
|
1,100
|
|
||
Proceeds from maturities of marketable securities
|
872
|
|
|
688
|
|
||
Proceeds from sale of long-lived assets and investments
|
7
|
|
|
21
|
|
||
Reimbursement of headquarters building development costs from banks
|
24
|
|
|
—
|
|
||
Purchases of property and equipment and intangible assets
|
(71
|
)
|
|
(91
|
)
|
||
Other
|
(1
|
)
|
|
(1
|
)
|
||
Net cash used in investing activities
|
(187
|
)
|
|
(409
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Proceeds from issuance of common stock under employee stock plans
|
99
|
|
|
129
|
|
||
Payments under capital lease obligations
|
(3
|
)
|
|
(2
|
)
|
||
Tax benefits from stock-based compensation
|
5
|
|
|
12
|
|
||
Payments related to repurchases of common stock
|
(452
|
)
|
|
(810
|
)
|
||
Dividends paid
|
(152
|
)
|
|
(140
|
)
|
||
Net cash used in financing activities
|
(503
|
)
|
|
(811
|
)
|
||
Change in cash and cash equivalents
|
(26
|
)
|
|
(757
|
)
|
||
Cash and cash equivalents at beginning of period
|
497
|
|
|
1,152
|
|
||
Cash and cash equivalents at end of period
|
$
|
471
|
|
|
$
|
395
|
|
|
|
|
|
||||
Other non-cash activity:
|
|
|
|
||||
Assets acquired by assuming related liabilities
|
$
|
—
|
|
|
$
|
14
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 25,
2015 |
|
October 26,
2014 |
|
October 25,
2015 |
|
October 26,
2014 |
||||||||
|
(In millions)
|
||||||||||||||
Cost of revenue
|
$
|
4
|
|
|
$
|
4
|
|
|
$
|
10
|
|
|
$
|
8
|
|
Research and development
|
28
|
|
|
22
|
|
|
82
|
|
|
65
|
|
||||
Sales, general and administrative
|
19
|
|
|
16
|
|
|
53
|
|
|
42
|
|
||||
Total
|
$
|
51
|
|
|
$
|
42
|
|
|
$
|
145
|
|
|
$
|
115
|
|
|
Awards Outstanding
|
|
Weighted Average Exercise Price
|
||
Stock Options
|
(In millions)
|
|
(Per share)
|
||
Balances, January 25, 2015
|
21
|
|
|
$14.61
|
|
Granted
|
—
|
|
|
—
|
|
Exercised
|
(6
|
)
|
|
$14.48
|
|
Cancelled
|
—
|
|
|
—
|
|
Balances, October 25, 2015
|
15
|
|
|
$14.55
|
|
Awards Outstanding
|
|
Weighted Average Grant-Date Fair Value
|
|
RSUs, PSUs and Market-based PSUs
|
(In millions)
|
|
(Per share)
|
|
Balances, January 25, 2015
|
23
|
|
|
$15.94
|
Granted (1) (2)
|
13
|
|
|
$21.61
|
Vested
|
(8
|
)
|
|
$15.53
|
Cancelled
|
(2
|
)
|
|
$16.40
|
Balances, October 25, 2015
|
26
|
|
|
$18.84
|
(1)
|
Includes the total PSUs that become eligible to vest if the corporate financial performance maximum target level for fiscal year 2016 is achieved. Using an estimate for the level of achievement of the corporate performance target at the end of fiscal year 2016, we are estimating PSUs that become eligible to vest for fiscal year 2016 performance to be in the range of
0
to
2 million
shares. We granted PSUs during the first quarter of fiscal year 2016 to our CEO and senior management as approved by our Compensation Committee.
|
(2)
|
Includes the market-based PSUs that become eligible to vest if the maximum target for total shareholder return, or TSR, over the 3-year measurement period is achieved. Depending on the ranking of our TSR compared to the respective TSRs of the companies comprising the Standard & Poor’s 500 Index during a 3-year measurement period, the market-based PSUs that become eligible to vest could range from
0
to
0.4 million
shares. We granted market-based PSUs during the first quarter of fiscal year 2016 to our CEO and senior management as approved by our Compensation Committee.
|
|
October 25,
|
|
January 25,
|
|
2015
|
|
2015
|
|
(In millions)
|
||
Aggregate unearned stock-based compensation expense
|
$420
|
|
$291
|
|
|
|
|
Estimated weighted average amortization period
|
(In years)
|
||
Stock options
|
1.3
|
|
1.8
|
RSUs, PSUs and market-based PSUs
|
3.0
|
|
2.8
|
ESPP
|
0.8
|
|
0.5
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 25,
|
|
October 26,
|
|
October 25,
|
|
October 26,
|
||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
|
(In millions, except per share data)
|
||||||||||||||
Numerator:
|
|
|
|
|
|
|
|
||||||||
Net income
|
$
|
246
|
|
|
$
|
173
|
|
|
$
|
406
|
|
|
$
|
437
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Denominator for basic net income per share, weighted average shares
|
542
|
|
|
548
|
|
|
544
|
|
|
555
|
|
||||
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Equity awards outstanding
|
13
|
|
|
10
|
|
|
13
|
|
|
11
|
|
||||
Assumed conversion of 1% Convertible Senior Notes Due 2018
|
10
|
|
|
—
|
|
|
6
|
|
|
—
|
|
||||
Denominator for diluted net income per share, weighted average shares
|
565
|
|
|
558
|
|
|
563
|
|
|
566
|
|
||||
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic net income per share
|
$
|
0.45
|
|
|
$
|
0.32
|
|
|
$
|
0.75
|
|
|
$
|
0.79
|
|
Diluted net income per share
|
$
|
0.44
|
|
|
$
|
0.31
|
|
|
$
|
0.72
|
|
|
$
|
0.77
|
|
Potentially dilutive equity awards excluded from diluted net income per share because their effect would have been anti-dilutive
|
9
|
|
|
11
|
|
|
13
|
|
|
16
|
|
|
October 25, 2015
|
||||||||||||||
|
Amortized
Cost
|
|
Unrealized
Gain
|
|
Unrealized
Loss
|
|
Estimated
Fair Value
|
||||||||
|
(In millions)
|
||||||||||||||
Corporate debt securities
|
$
|
1,975
|
|
|
$
|
2
|
|
|
$
|
(2
|
)
|
|
$
|
1,975
|
|
Debt securities of U.S. government agencies
|
994
|
|
|
1
|
|
|
—
|
|
|
995
|
|
||||
Debt securities issued by the U.S. Treasury
|
554
|
|
|
1
|
|
|
—
|
|
|
555
|
|
||||
Asset-backed securities
|
472
|
|
|
—
|
|
|
—
|
|
|
472
|
|
||||
Mortgage-backed securities issued by U.S. government-sponsored enterprises
|
240
|
|
|
4
|
|
|
(1
|
)
|
|
243
|
|
||||
Foreign government bonds
|
83
|
|
|
—
|
|
|
—
|
|
|
83
|
|
||||
Money market funds
|
30
|
|
|
—
|
|
|
—
|
|
|
30
|
|
||||
Total
|
$
|
4,348
|
|
|
$
|
8
|
|
|
$
|
(3
|
)
|
|
$
|
4,353
|
|
Classified as:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cash equivalents
|
|
|
|
|
|
|
|
|
|
$
|
96
|
|
|||
Marketable securities
|
|
|
|
|
|
|
|
|
|
4,257
|
|
||||
Total
|
|
|
|
|
|
|
|
|
|
$
|
4,353
|
|
|
January 25, 2015
|
||||||||||||||
|
Amortized
Cost |
|
Unrealized
Gain |
|
Unrealized
Loss |
|
Estimated
Fair Value |
||||||||
|
(In millions)
|
||||||||||||||
Corporate debt securities
|
$
|
2,185
|
|
|
$
|
2
|
|
|
$
|
(1
|
)
|
|
$
|
2,186
|
|
Debt securities of U.S. government agencies
|
750
|
|
|
1
|
|
|
(1
|
)
|
|
750
|
|
||||
Debt securities issued by the U.S. Treasury
|
534
|
|
|
3
|
|
|
—
|
|
|
537
|
|
||||
Asset-backed securities
|
453
|
|
|
—
|
|
|
—
|
|
|
453
|
|
||||
Mortgage-backed securities issued by U.S. government-sponsored enterprises
|
274
|
|
|
5
|
|
|
(1
|
)
|
|
278
|
|
||||
Foreign government bonds
|
85
|
|
|
—
|
|
|
—
|
|
|
85
|
|
||||
Money market funds
|
132
|
|
|
—
|
|
|
—
|
|
|
132
|
|
||||
Total
|
$
|
4,413
|
|
|
$
|
11
|
|
|
$
|
(3
|
)
|
|
$
|
4,421
|
|
Classified as:
|
|
|
|
|
|
|
|
||||||||
Cash equivalents
|
|
|
|
|
|
|
$
|
295
|
|
||||||
Marketable securities
|
|
|
|
|
|
|
4,126
|
|
|||||||
Total
|
|
|
|
|
|
|
$
|
4,421
|
|
|
Less than 12 months
|
|
12 months or greater
|
|
Total
|
||||||||||||||||||
|
Fair Value
|
|
Gross
Unrealized
Losses
|
|
Fair Value
|
|
Gross
Unrealized
Losses
|
|
Fair Value
|
|
Gross
Unrealized
Losses
|
||||||||||||
|
(In millions)
|
||||||||||||||||||||||
Corporate debt securities
|
$
|
798
|
|
|
$
|
(2
|
)
|
|
$
|
54
|
|
|
$
|
—
|
|
|
$
|
852
|
|
|
$
|
(2
|
)
|
Mortgage-backed securities issued by U.S. government-sponsored enterprises
|
73
|
|
|
(1
|
)
|
|
26
|
|
|
—
|
|
|
99
|
|
|
(1
|
)
|
||||||
Total
|
$
|
871
|
|
|
$
|
(3
|
)
|
|
$
|
80
|
|
|
$
|
—
|
|
|
$
|
951
|
|
|
$
|
(3
|
)
|
|
October 25, 2015
|
|
January 25, 2015
|
||||||||||||
|
Amortized
Cost
|
|
Estimated
Fair Value
|
|
Amortized
Cost
|
|
Estimated
Fair Value
|
||||||||
|
(In millions)
|
||||||||||||||
Less than 1 year
|
$
|
1,453
|
|
|
$
|
1,454
|
|
|
$
|
1,570
|
|
|
$
|
1,571
|
|
Due in 1 - 5 years
|
2,811
|
|
|
2,815
|
|
|
2,720
|
|
|
2,726
|
|
||||
Mortgage-backed securities issued by government-sponsored enterprises not due at a single maturity date
|
84
|
|
|
84
|
|
|
123
|
|
|
124
|
|
||||
Total
|
$
|
4,348
|
|
|
$
|
4,353
|
|
|
$
|
4,413
|
|
|
$
|
4,421
|
|
|
|
Fair Value at
|
|||||||
|
Pricing Category
|
|
October 25, 2015
|
|
January 25, 2015
|
||||
|
|
|
(In millions)
|
||||||
Assets
|
|
|
|
|
|
||||
Cash equivalents and Marketable securities
|
|
|
|
|
|
||||
Corporate debt securities (1)
|
Level 2
|
|
$
|
1,975
|
|
|
$
|
2,186
|
|
Debt securities of U.S. government agencies (2)
|
Level 2
|
|
$
|
995
|
|
|
$
|
750
|
|
Debt securities issued by the U.S. Treasury (3)
|
Level 2
|
|
$
|
555
|
|
|
$
|
537
|
|
Asset-backed securities (4)
|
Level 2
|
|
$
|
472
|
|
|
$
|
453
|
|
Mortgage-backed securities issued by government-sponsored enterprises (3)
|
Level 2
|
|
$
|
243
|
|
|
$
|
278
|
|
Foreign government bonds (3)
|
Level 2
|
|
$
|
83
|
|
|
$
|
85
|
|
Money market funds (5)
|
Level 1
|
|
$
|
30
|
|
|
$
|
132
|
|
|
|
|
|
|
|
||||
Liabilities
|
|
|
|
|
|
||||
Other noncurrent liabilities
|
|
|
|
|
|
||||
Interest rate swap (6)
|
Level 2
|
|
$
|
3
|
|
|
$
|
—
|
|
1.00% Convertible Senior Notes Due 2018 (7)
|
Level 2
|
|
$
|
2,198
|
|
|
$
|
1,680
|
|
(1)
|
Includes
$51 million
and
$147 million
in cash equivalents as of October 25, 2015 and January 25, 2015, respectively, and
$1.9 billion
and
$2.0 billion
in marketable securities as of October 25, 2015 and January 25, 2015, respectively, on the Condensed Consolidated Balance Sheets.
|
(2)
|
Includes
$14 million
and
$15 million
in cash equivalents as of October 25, 2015 and January 25, 2015, respectively, and
$981 million
and
$735 million
in marketable securities as of October 25, 2015 and January 25, 2015, respectively, on the Condensed Consolidated Balance Sheets.
|
(3)
|
In marketable securities on the Condensed Consolidated Balance Sheets.
|
(4)
|
Includes
$1 million
in cash equivalents as of October 25, 2015 and $
471 million
and
$453 million
in marketable securities as of October 25, 2015 and January 25, 2015, respectively, on the Condensed Consolidated Balance Sheets.
|
(5)
|
In cash equivalents on the Condensed Consolidated Balance Sheets.
|
(6)
|
Please refer to Note 9 of these Notes to Condensed Consolidated Financial Statements for a discussion regarding our interest rate swap.
|
|
October 25, 2015
|
|
January 25, 2015
|
||||||||||||||||||||
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net Carrying
Amount
|
|
Gross
Carrying
Amount
|
|
Accumulated Amortization
|
|
Net Carrying
Amount
|
||||||||||||
|
(In millions)
|
||||||||||||||||||||||
Acquisition-related intangible assets
|
$
|
193
|
|
|
$
|
(148
|
)
|
|
$
|
45
|
|
|
$
|
189
|
|
|
$
|
(134
|
)
|
|
$
|
55
|
|
Patents and licensed technology
|
451
|
|
|
(324
|
)
|
|
127
|
|
|
449
|
|
|
(282
|
)
|
|
167
|
|
||||||
Total intangible assets
|
$
|
644
|
|
|
$
|
(472
|
)
|
|
$
|
172
|
|
|
$
|
638
|
|
|
$
|
(416
|
)
|
|
$
|
222
|
|
|
October 25,
|
|
January 25,
|
||||
|
2015
|
|
2015
|
||||
Inventories:
|
(In millions)
|
||||||
Raw materials
|
$
|
117
|
|
|
$
|
157
|
|
Work in-process
|
91
|
|
|
92
|
|
||
Finished goods
|
217
|
|
|
234
|
|
||
Total inventories
|
$
|
425
|
|
|
$
|
483
|
|
|
October 25,
|
|
January 25,
|
||||
|
2015
|
|
2015
|
||||
Accrued and Other Current Liabilities:
|
(In millions)
|
||||||
Unearned revenue (1)
|
$
|
229
|
|
|
$
|
296
|
|
Customer related liabilities (2)
|
151
|
|
|
143
|
|
||
Accrued payroll and related expenses
|
98
|
|
|
112
|
|
||
Professional service fees
|
24
|
|
|
17
|
|
||
Accrued restructuring and other charges (3)
|
15
|
|
|
—
|
|
||
Warranty accrual (4)
|
13
|
|
|
8
|
|
||
Taxes payable
|
7
|
|
|
3
|
|
||
Coupon interest on Notes
|
6
|
|
|
3
|
|
||
Facilities related liabilities
|
1
|
|
|
8
|
|
||
Other
|
16
|
|
|
13
|
|
||
Total accrued and other current liabilities
|
$
|
560
|
|
|
$
|
603
|
|
(1)
|
Unearned revenue primarily includes deferred revenue.
|
(2)
|
Customer related liabilities primarily includes accrued customer programs. Please refer to Note 1 of the Notes to the Consolidated Financial Statements in our Annual Report on Form 10-K for the fiscal year ended
January 25, 2015
, for a discussion regarding the nature of accrued customer programs and their accounting treatment related to our revenue recognition policies and estimates.
|
(3)
|
Please refer to Note 15 of these Notes to Condensed Consolidated Financial Statements for a discussion regarding the accrued restructuring and other charges.
|
(4)
|
Please refer to Note 10 of these Notes to Condensed Consolidated Financial Statements for a discussion regarding the warranty accrual.
|
|
October 25,
|
|
January 25,
|
||||
|
2015
|
|
2015
|
||||
Other Long-Term Liabilities:
|
(In millions)
|
||||||
Deferred income tax liability
|
$
|
325
|
|
|
$
|
232
|
|
Income taxes payable
|
76
|
|
|
121
|
|
||
Asset retirement obligation
|
7
|
|
|
7
|
|
||
Interest rate swap (1)
|
3
|
|
|
—
|
|
||
Deferred revenue (2)
|
1
|
|
|
108
|
|
||
Other
|
25
|
|
|
21
|
|
||
Total other long-term liabilities
|
$
|
437
|
|
|
$
|
489
|
|
(1)
|
Please refer to Note 9 of these Notes to Condensed Consolidated Financial Statements for a discussion regarding our interest rate swap.
|
|
Notional Amount
|
|
Fair Value Asset (Liability)
|
||||||||||||
|
October 25, 2015
|
|
January 25, 2015
|
|
October 25, 2015
|
|
January 25, 2015
|
||||||||
Cash Flow Hedge
|
|
|
|
|
|
|
|
||||||||
Interest rate swap
|
$
|
200
|
|
|
$
|
—
|
|
|
$
|
(3
|
)
|
|
$
|
—
|
|
|
October 25, 2015
|
|
January 25, 2015
|
||||
Cash Flow Hedge
|
|
|
|
||||
Gain (loss) on interest rate swap
|
$
|
(3
|
)
|
|
$
|
—
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 25,
|
|
October 26,
|
|
October 25,
|
|
October 26,
|
||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
|
(In millions)
|
||||||||||||||
Balance at beginning of period
|
$
|
28
|
|
|
$
|
8
|
|
|
$
|
8
|
|
|
$
|
8
|
|
Additions
|
—
|
|
|
1
|
|
|
22
|
|
|
4
|
|
||||
Deductions
|
(15
|
)
|
|
(2
|
)
|
|
(17
|
)
|
|
(5
|
)
|
||||
Balance at end of period
|
$
|
13
|
|
|
$
|
7
|
|
|
$
|
13
|
|
|
$
|
7
|
|
|
|
October 25,
|
|
January 25,
|
||||
|
|
2015
|
|
2015
|
||||
|
|
(In millions)
|
||||||
Amount of the equity component
|
|
$
|
126
|
|
|
$
|
126
|
|
|
|
|
|
|
||||
1.00% Convertible Senior Notes Due 2018
|
|
$
|
1,500
|
|
|
$
|
1,500
|
|
Unamortized debt discount (1)
|
|
(94
|
)
|
|
(116
|
)
|
||
Net carrying amount
|
|
$
|
1,406
|
|
|
$
|
1,384
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
October 25,
|
|
October 26,
|
|
October 25,
|
|
October 26,
|
||||||||
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
|
|
(In millions)
|
||||||||||||||
Contractual coupon interest expense
|
|
$
|
4
|
|
|
$
|
4
|
|
|
$
|
11
|
|
|
$
|
11
|
|
Amortization of debt discount and issuance costs
|
|
7
|
|
|
7
|
|
|
22
|
|
|
21
|
|
||||
Total interest expense related to Notes
|
|
$
|
11
|
|
|
$
|
11
|
|
|
$
|
33
|
|
|
$
|
32
|
|
|
GPU
|
|
Tegra Processor
|
|
All Other
|
|
Consolidated
|
||||||||
|
(In millions)
|
||||||||||||||
Three Months Ended October 25, 2015
|
|
|
|
|
|
|
|
||||||||
Revenue
|
$
|
1,110
|
|
|
$
|
129
|
|
|
$
|
66
|
|
|
$
|
1,305
|
|
Depreciation and amortization expenses
|
$
|
26
|
|
|
$
|
11
|
|
|
$
|
11
|
|
|
$
|
48
|
|
Operating income (loss)
|
$
|
367
|
|
|
$
|
(65
|
)
|
|
$
|
(57
|
)
|
|
$
|
245
|
|
|
|
|
|
|
|
|
|
||||||||
Three Months Ended October 26, 2014
|
|
|
|
|
|
|
|
|
|
|
|
||||
Revenue
|
$
|
991
|
|
|
$
|
168
|
|
|
$
|
66
|
|
|
$
|
1,225
|
|
Depreciation and amortization expenses
|
$
|
29
|
|
|
$
|
15
|
|
|
$
|
12
|
|
|
$
|
56
|
|
Operating income (loss)
|
$
|
294
|
|
|
$
|
(53
|
)
|
|
$
|
(28
|
)
|
|
$
|
213
|
|
|
|
|
|
|
|
|
|
||||||||
Nine Months Ended October 25, 2015
|
|
|
|
|
|
|
|
|
|
|
|
||||
Revenue
|
$
|
3,009
|
|
|
$
|
402
|
|
|
$
|
198
|
|
|
$
|
3,609
|
|
Depreciation and amortization expense
|
$
|
81
|
|
|
$
|
36
|
|
|
$
|
34
|
|
|
$
|
151
|
|
Operating income (loss)
|
$
|
917
|
|
|
$
|
(164
|
)
|
|
$
|
(258
|
)
|
|
$
|
495
|
|
|
|
|
|
|
|
|
|
||||||||
Nine Months Ended October 26, 2014
|
|
|
|
|
|
|
|
|
|
|
|
||||
Revenue
|
$
|
2,767
|
|
|
$
|
466
|
|
|
$
|
198
|
|
|
$
|
3,431
|
|
Depreciation and amortization expense
|
$
|
88
|
|
|
$
|
43
|
|
|
$
|
35
|
|
|
$
|
166
|
|
Operating income (loss)
|
$
|
770
|
|
|
$
|
(169
|
)
|
|
$
|
(73
|
)
|
|
$
|
528
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 25,
2015 |
|
October 26,
2014 |
|
October 25,
2015 |
|
October 26,
2014 |
||||||||
|
(In millions)
|
||||||||||||||
Reconciling items included in "All Other" category:
|
|
|
|
|
|
|
|||||||||
Unallocated revenue
|
$
|
66
|
|
|
$
|
66
|
|
|
$
|
198
|
|
|
$
|
198
|
|
Unallocated cost of revenue and operating expenses
|
(60
|
)
|
|
(42
|
)
|
|
(181
|
)
|
|
(128
|
)
|
||||
Stock-based compensation
|
(51
|
)
|
|
(42
|
)
|
|
(145
|
)
|
|
(115
|
)
|
||||
Acquisition-related costs
|
(4
|
)
|
|
(10
|
)
|
|
(18
|
)
|
|
(28
|
)
|
||||
Product warranty charge
|
—
|
|
|
—
|
|
|
(15
|
)
|
|
—
|
|
||||
Restructuring and other charges
|
(8
|
)
|
|
—
|
|
|
(97
|
)
|
|
—
|
|
||||
Total
|
$
|
(57
|
)
|
|
$
|
(28
|
)
|
|
$
|
(258
|
)
|
|
$
|
(73
|
)
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 25,
|
|
October 26,
|
|
October 25,
|
|
October 26,
|
||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
|
(In millions)
|
||||||||||||||
Revenue:
|
|
|
|
|
|
|
|
||||||||
Taiwan
|
$
|
515
|
|
|
$
|
406
|
|
|
$
|
1,348
|
|
|
$
|
1,109
|
|
China
|
229
|
|
|
238
|
|
|
583
|
|
|
714
|
|
||||
Other Asia Pacific
|
181
|
|
|
170
|
|
|
554
|
|
|
475
|
|
||||
United States
|
156
|
|
|
215
|
|
|
474
|
|
|
595
|
|
||||
Europe
|
116
|
|
|
96
|
|
|
341
|
|
|
263
|
|
||||
Other Americas
|
108
|
|
|
100
|
|
|
309
|
|
|
275
|
|
||||
Total revenue
|
$
|
1,305
|
|
|
$
|
1,225
|
|
|
$
|
3,609
|
|
|
$
|
3,431
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||
|
October 25,
|
|
October 25,
|
||||
|
2015
|
|
2015
|
||||
|
(In millions)
|
||||||
Employee severance and related costs
|
$
|
2
|
|
|
$
|
58
|
|
Tax subsidy impairment
|
—
|
|
|
17
|
|
||
Fixed assets impairment
|
3
|
|
|
14
|
|
||
Facilities and related costs
|
2
|
|
|
4
|
|
||
Other exit costs
|
1
|
|
|
4
|
|
||
Restructuring and other charges
|
$
|
8
|
|
|
$
|
97
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||
|
October 25,
|
|
October 25,
|
||||
|
2015
|
|
2015
|
||||
|
(In millions)
|
||||||
Balance at beginning of period
|
$
|
18
|
|
|
$
|
—
|
|
Restructuring and other charges
|
8
|
|
|
97
|
|
||
Cash payments
|
(7
|
)
|
|
(46
|
)
|
||
Non-cash adjustments
|
(4
|
)
|
|
(36
|
)
|
||
Balance at end of period
|
$
|
15
|
|
|
$
|
15
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||
|
October 25,
2015 |
|
October 26,
2014 |
|
October 25,
2015 |
|
October 26,
2014 |
||||
Revenue
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
Cost of revenue
|
43.8
|
|
|
44.8
|
|
|
44.0
|
|
|
44.6
|
|
Gross profit
|
56.2
|
|
|
55.2
|
|
|
56.0
|
|
|
55.4
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
25.2
|
|
|
27.8
|
|
|
27.3
|
|
|
29.5
|
|
Sales, general and administrative
|
11.6
|
|
|
10.1
|
|
|
12.2
|
|
|
10.5
|
|
Restructuring and other charges
|
0.6
|
|
|
—
|
|
|
2.7
|
|
|
—
|
|
Total operating expenses
|
37.4
|
|
|
37.9
|
|
|
42.2
|
|
|
40.0
|
|
Operating income
|
18.9
|
|
|
17.3
|
|
|
13.8
|
|
|
15.4
|
|
Interest income
|
0.7
|
|
|
0.6
|
|
|
0.8
|
|
|
0.6
|
|
Interest expense
|
(0.9
|
)
|
|
(0.9
|
)
|
|
(1.0
|
)
|
|
(1.0
|
)
|
Other income, net
|
0.2
|
|
|
—
|
|
|
—
|
|
|
0.4
|
|
Income before income tax
|
18.9
|
|
|
17.0
|
|
|
13.6
|
|
|
15.4
|
|
Income tax expense (benefit)
|
(0.1
|
)
|
|
2.9
|
|
|
2.3
|
|
|
2.6
|
|
Net income
|
19.0
|
%
|
|
14.1
|
%
|
|
11.3
|
%
|
|
12.8
|
%
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||||||||||||||||
|
October 25,
2015 |
|
October 26,
2014 |
|
$
Change |
|
%
Change |
|
October 25,
2015 |
|
October 26,
2014 |
|
$
Change |
|
%
Change |
||||||||||||||
|
(In millions)
|
|
|
|
(In millions)
|
|
|
||||||||||||||||||||||
GPU
|
$
|
1,110
|
|
|
$
|
991
|
|
|
$
|
119
|
|
|
12
|
%
|
|
$
|
3,009
|
|
|
$
|
2,767
|
|
|
$
|
242
|
|
|
9
|
%
|
Tegra Processor
|
129
|
|
|
168
|
|
|
(39
|
)
|
|
(23
|
)
|
|
402
|
|
|
466
|
|
|
(64
|
)
|
|
(14
|
)
|
||||||
All Other
|
66
|
|
|
66
|
|
|
—
|
|
|
—
|
|
|
198
|
|
|
198
|
|
|
—
|
|
|
—
|
|
||||||
Total
|
$
|
1,305
|
|
|
$
|
1,225
|
|
|
$
|
80
|
|
|
7
|
%
|
|
$
|
3,609
|
|
|
$
|
3,431
|
|
|
$
|
178
|
|
|
5
|
%
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||||||||||||||||
|
October 25,
2015 |
|
October 26,
2014 |
|
$
Change
|
|
%
Change
|
|
October 25,
2015 |
|
October 26,
2014 |
|
$
Change
|
|
%
Change
|
||||||||||||||
|
(In millions)
|
|
|
|
(In millions)
|
|
|
||||||||||||||||||||||
Research and development expenses
|
$
|
329
|
|
|
$
|
340
|
|
|
$
|
(11
|
)
|
|
(3
|
)%
|
|
$
|
987
|
|
|
$
|
1,011
|
|
|
$
|
(24
|
)
|
|
(2
|
)%
|
Sales, general and administrative expenses
|
152
|
|
|
123
|
|
|
29
|
|
|
24
|
|
|
441
|
|
|
361
|
|
|
80
|
|
|
22
|
|
||||||
Restructuring and other charges
|
8
|
|
|
—
|
|
|
8
|
|
|
100
|
|
|
97
|
|
|
—
|
|
|
97
|
|
|
100
|
|
||||||
Total operating expenses
|
$
|
489
|
|
|
$
|
463
|
|
|
$
|
26
|
|
|
6
|
%
|
|
$
|
1,525
|
|
|
$
|
1,372
|
|
|
$
|
153
|
|
|
11
|
%
|
Research and development as a percentage of net revenue
|
25
|
%
|
|
28
|
%
|
|
|
|
|
|
|
|
27
|
%
|
|
29
|
%
|
|
|
|
|
|
|
||||||
Sales, general and administrative as a percentage of net revenue
|
12
|
%
|
|
10
|
%
|
|
|
|
|
|
|
|
12
|
%
|
|
11
|
%
|
|
|
|
|
|
|
||||||
Restructuring and other charges as a percentage of net revenue
|
1
|
%
|
|
—
|
%
|
|
|
|
|
|
3
|
%
|
|
—
|
%
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||
|
October 25,
|
|
October 25,
|
||||
|
2015
|
|
2015
|
||||
|
(In millions)
|
||||||
Employee severance and related costs
|
$
|
2
|
|
|
$
|
58
|
|
Tax subsidy impairment
|
—
|
|
|
17
|
|
||
Fixed assets impairment
|
3
|
|
|
14
|
|
||
Facilities and related costs
|
2
|
|
|
4
|
|
||
Other exit costs
|
1
|
|
|
4
|
|
||
Restructuring and other charges
|
$
|
8
|
|
|
$
|
97
|
|
|
As of
|
||||||
|
October 25, 2015
|
|
January 25, 2015
|
||||
|
(In millions)
|
||||||
Cash and cash equivalents
|
$
|
471
|
|
|
$
|
497
|
|
Marketable securities
|
4,257
|
|
|
4,126
|
|
||
Cash, cash equivalents, and marketable securities
|
$
|
4,728
|
|
|
$
|
4,623
|
|
|
Nine Months Ended
|
||||||
|
October 25, 2015
|
|
October 26, 2014
|
||||
|
(In millions)
|
||||||
Net cash provided by operating activities
|
$
|
664
|
|
|
$
|
463
|
|
Net cash used in investing activities
|
$
|
(187
|
)
|
|
$
|
(409
|
)
|
Net cash used in financing activities
|
$
|
(503
|
)
|
|
$
|
(811
|
)
|
Period
|
|
Total Number of Shares Purchased
|
|
Average Price Paid per Share (1)
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
|
||||||
July 27, 2015 - August 23, 2015
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
1,600
|
|
August 24, 2015 - September 20, 2015
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
1,600
|
|
|
September 21, 2015 - October 25, 2015
|
|
4
|
|
|
—
|
|
|
4
|
|
|
$
|
1,600
|
|
|
Total
|
|
4
|
|
|
$
|
—
|
|
|
4
|
|
|
|
Exhibit No.
|
|
Exhibit Description
|
|
Schedule
/Form
|
|
File Number
|
|
Exhibit
|
|
Filing Date
|
31.1*
|
|
Certification of Chief Executive Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
31.2*
|
|
Certification of Chief Financial Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
32.1#*
|
|
Certification of Chief Executive Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
32.2#*
|
|
Certification of Chief Financial Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
101.INS*
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
|
|
|
|
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
NVIDIA Corporation
|
||
By:
|
/s/ Colette M. Kress
|
|
|
|
|
|
|
|
Colette M. Kress
|
||
|
Executive Vice President and Chief Financial Officer (Duly Authorized Officer and Principal Financial Officer)
|
Exhibit No.
|
|
Exhibit Description
|
|
Schedule
/Form
|
|
File Number
|
|
Exhibit
|
|
Filing Date
|
31.1*
|
|
Certification of Chief Executive Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
31.2*
|
|
Certification of Chief Financial Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
32.1#*
|
|
Certification of Chief Executive Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
32.2#*
|
|
Certification of Chief Financial Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
101.INS*
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
|
|
|
|
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|